MAFTIVIMAB
UNII KOP95331M4

Substance Identification & Data

This profile provides standardized clinical and technical data for Maftivimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KOP95331M4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2135632-36-7 and the RxNorm Concept ID (RxCUI) 2461339. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KOP95331M4

CAS Registry Number

2135632-36-7

RxNorm Concept ID

2461339

Detailed Substance Profile

Preferred Name

MAFTIVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

KOP95331M4

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C170146

National Cancer Institute reference terminology for clinical and research data.

INN ID

11034

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-103

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Maftivimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MAFTIVIMAB

MAFTIVIMAB-EBGN

Common Names & Synonyms

MAFTIVIMAB [INN]

MAFTIVIMAB [USAN]

MAFTIVIMAB [WHO-DD]

REGN-3479

REGN-EB3 COMPONENT MAFTIVIMAB

Brand / Trade Names

INMAZEB COMPONENT MAFTIVIMAB-EBGN

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN) (HUMAN MONOCLONAL REGN3479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN3479 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS (ZAIRE EBOLA VIRUS (EBOV)) GLYCOPROTEIN), HOMO SAPIENS MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HOMO SAPIENS (1-448) (VH (HOMO SAPIENS IGHV3-23*04 (95.9%)-(IGHD)-IGHJ3*02(93.3%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (215) (119-216), HINGE (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (98.9%)-IGKJ5*01(91.7%)) (6.3.8) (1'-106')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (106'-213'))DIMER (227-227'':230-230'')-BISDISULFIDE

SYS